2026/08/03
Following IPVC 2025 in Bangkok, global attention now turns to the next International Papillomavirus Conference.
Conference Overview
The 38th International Papillomavirus Conference (IPVC 2026) will be held in Athens, Greece, from October 22–25, 2026, hosted by the International Papillomavirus Society (IPVS).
The conference will bring together leading researchers, clinicians, and public health experts from around the world to share the latest advances in papillomavirus research. Through symposia, invited lectures, oral presentations, and poster sessions, IPVC 2026 will provide an important international platform for scientific exchange across basic research, clinical research, and public health.
REBACIN® R&D Team at IPVC 2026
The REBACIN® R&D team will attend the conference, with the Executive Vice President (EVP) of SR BioPharma Pte. Ltd., presenting the team’s research entitled “REBACIN® for Persistent High-Risk HPV Infection: Mechanistic Insights, Localized Sustained Delivery, and Real-World Clinical Outcomes.” The presentation will highlight recent research on REBACIN® for persistent high-risk HPV (hrHPV) infection, including its mechanism of action, localized sustained delivery, and real-world clinical outcomes.
Since first participating in IPVC in 2010, the REBACIN® R&D team has presented research at 12 consecutive IPVC conferences, including four oral presentations.
See You in Athens
IPVC 2026 will provide an important international platform for scientific exchange and collaboration across basic research, clinical translation, and public health.
The REBACIN® R&D team looks forward to meeting researchers and clinicians from around the world in Athens and exchanging perspectives on advances in HPV research, prevention, and treatment.
